Palonosetron in Sarcoma Patients Receiving Chemotherapy With Adriamycin and Ifosfamide (AI)
Status:
Completed
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to compare 2 treatment schedules of Aloxi
(palonosetron) in patients with sarcoma who are receiving chemotherapy with adriamycin and
ifosfamide. The safety of the drug and schedules will be studied. The effect of palonosetron
on patients' quality of life (QOL) will also be studied.